Despite the hype, this buzzing AI will still have to prove its worth for Asia’s cautious hospitals, says one health tech vendor.
Slow and steady uptake of genAI in APAC healthcare in 2024
Despite the hype, this buzzing AI will still have to prove its worth for Asia’s cautious hospitals, says one health tech vendor.
